Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms. However, new research offers fresh hope ...

Anyone who attended St. Michael's Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers ...

Globally, there are about 500,000 new cases of drug-resistant TB every year, about 5 percent of the 9 million new TB cases. In the United States, 1.2 percent of TB cases were multi-drug-resistant.

Source Reference: Saukkonen JJ, et al "Updates on the treatment of drug-susceptible and drug-resistant tuberculosis: An official ATS/CDC/ERS/IDSA clinical practice guideline" Am J Respir Crit Care ...

Yet there is also a far nastier form of TB. In 2023, an estimated 400,000 people developed different types of “drug-resistant” TB, which are much more difficult to treat and far more likely to ...

"Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people each year. It is associated with significantly poorer outcomes than drug-susceptible TB," said ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Clinical trial finds three new ways to treat drug-resistant tuberculosis. Strains like these sicken 410,000 people each year. By Laura Baisas. Published Jan 29, 2025 5:00 PM EST ...

Anyone who attended St. Michael’s Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug ...

Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms.. However, new research offers fresh hope ...